In-vitro Fertilization Microscopes Market Size, Share & Trends Analysis Report By End-use (Clinical, Academic Research), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2023 - 2030

Report Overview

The global in-vitro fertilization microscopes market size was valued at USD 101.6 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.41% from 2023 to 2030. In-vitro fertilization (IVF) is a procedure classified under assisted reproductive technologies (ART). These microscopes in IVF are widely used for oocyte preparation, semen analysis, in-vitro fertilization, and embryo overall analysis. The improving success rate of in-vitro fertilization procedures, changing demographics and societal norms, and the availability of financial assistance are expected to boost market growth. Furthermore, technological advancement in the product by manufacturers is enhancing treatment efficiency further reducing the procedure costs.

Improved quality of microscopic examination by high contrast and innovations in the IVF microscope-related equipment are some of the important advancements in the market. For instance, in July 2022, Esco Lifesciences Group announced the acquisition of Evidence Solution, a software company catering to IVF quality management systems & management technologies. The Evidence witness system embeds workflow scheduling, labeling, & traceability system built for IVF clinics to prevent errors in treatment.

The removal of embryos from an optimized culture environment to inspect for cleavage and morphology increases stress, thus limiting the number of assessments that can be performed. The system used for embryo monitoring by time-lapse technology incorporates a microscope and camera inside the incubation system, which enables noninvasive microscopic imaging of the embryo at specific time intervals.

The rising prevalence of infertility among men and women is expected to foster the growth of the market during the forecast period. According to the World Health Organization data, approximately 186 million people and about 60 to 80 million couples are suffering from infertility globally. Also, Cofertility noted that in 2021, 2.4% of babies in the U.S. were born with the support of assisted reproductive technologies (ART). Alternatively, 368,502 ART cycles occurred in the United States in 2021, a 19% increase from 2020.

Furthermore, during COVID-19 the In-vitro fertilization microscopes market had witnessed a negative impact. Post declaration of the COVID-19 pandemic by WHO, in March 2020, fertility organizations worldwide recommended ceasing IVF treatment, except for essential medical fertility preservation. This led to a decrease in the number of patients opting for IVF treatments, in turn affecting the demand for consumables, devices, and services by fertility centers.

The reopening of IVF centers started in 2021 with measures such as ensuring adequate staff, decontamination & validation of equipment, and completion of risk assessment about viral contamination. Digital health and telehealth adoption paved the way to overcome the negative impact of COVID-19.

Additionally, the companies operating in the market must follow the guidelines led by the authorities such as the American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology, and others. Considering the increasing awareness about IVF services, developing nations have also taken measures to introduce regulations.

End-use Insights

The clinical segment is anticipated to dominate the market with a revenue share of 94.6% in 2022. Major factors contributing to the segment growth include increasing awareness regarding IVF treatment and growing investments by private investors in infertility clinics.

IVF clinics provide a range of services including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing & storage of embryos. The growing trend for innovating microscope products in IVF clinics and increased investments from private investors in IVF clinics are expected to drive growth. The adoption of advanced microscopy products in IVF clinics is expected to help in reducing IVF costs for patients by reducing processing time and increasing efficiency. Similarly, there is also innovation in products used for oocyte analysis.

Besides, the rising use of a variety of microscopes in clinical ART procedures is expected to boost the growth of the segment during the forecast period. Microscopes are used in clinical ART facilities to accomplish gamete selection and clinical procedures. Stereo microscopes and upright microscopes both types of microscopes are used in clinical settings, ones with an inverted design are the most adaptable for ART. This microscope can assist clinics in tailoring treatment plans.

Regional Insights

Europe dominated the IVF fertilization microscopes market in 2022 with a share of 38.2% due to factors such as legal reforms, growing fertility tourism, and product innovation. The region has observed a significant adoption of IVF time-lapse technology with clinic-designed algorithms. Innovation in microscopes providing all imaging requirements used in a single embryo chamber to reduce the requirement of multiple workstations is aiding in saving space and the cost of the procedure.

Companies operating in the region are adopting various strategies including research initiatives, product launches, and others to propel the market growth during the forecast. For instance, in August 2021, Nikon Microscopes launched ECLIPSE Ti2-U IVF for the early procedures in the intracytoplasmic Sperm Injection (ICSI).

Asia Pacific is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness and availability of IVF services. The presence of a large population and increasing awareness regarding IVF are among the key factors contributing to the increased demand for microscopes by clinics.

Key Companies & Market Share Insights

Key players are adopting strategies such as geographic expansion and product innovation by integrating the latest technology to increase their market share. Market players such as Olympus Corporation; Leica Microsystems; and Nikon Corporation are major microscope manufacturers for IVF, and Hamilton Thorne Ltd. and Eppendorf AG are the key players in the microscope market. For instance, in May 2021, Hamilton Thorne Ltd acquired Tek-Event Pty Ltd. The acquisition will allow the company to expand its product portfolio with Tek-Event’s Cell-Tek Microscope Chamber. Some prominent players in the In-vitro fertilization microscopes market include:

• LINKAM SCIENTIFIC INSTRUMENTS

• Olympus Corporation

• Leica Microsystems

• Meiji Techno

• Zeiss

• Euromex Microscopen B.V.

• Labomed

• Nikon Corporation

• Narishige Group

• Eppendorf

• Hamilton Thorne Ltd.

• Sutter Instrument Company

• Tritech Research, Inc.

In-vitro Fertilization Microscopes Market Report Scope

Global In-vitro Fertilization Microscopes Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global in-vitro fertilization microscopes market report based on end-use and region:

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical

  • Academic Research

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait